• 1. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
• 2. Fast synthesis of copper nanoclusters through the use of hydrogen peroxide additive and their application for the fluorescence detection of Hg2+ in water samples?
  Liao Xiaoqing,Li Ruiyi,Li Zaijun,Sun Xiulan,Wang Zhouping,Liu Junkang New J. Chem., 2015,39, 5240-5248
• 3. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
• 4. Excitation energies from ground-state density-functionals by means of generator coordinates
  A. B. F. da Silva,K. Capelle Phys. Chem. Chem. Phys., 2009,11, 4564-4569
• 5. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161

2-(Difluoromethyl)-4-methylpyridine-5-sulfonyl chloride: A Versatile Intermediate in Medicinal Chemistry and Drug Discovery

2-(Difluoromethyl)-4-methylpyridine-5-sulfonyl chloride, with the chemical identifier CAS No. 1805273-66-8, represents a critical synthetic intermediate in the development of pyridine-based therapeutic agents. This compound belongs to the broader class of pyridine derivatives, which are widely utilized in pharmaceutical research due to their unique electronic properties and structural versatility. The 5-sulfonyl chloride functional group in this molecule serves as a key site for further chemical modifications, enabling the synthesis of diverse bioactive compounds. Recent advancements in synthetic chemistry have highlighted its potential as a building block for targeting specific enzyme families and receptor pathways associated with diseases such as cancer, neurodegeneration, and metabolic disorders.

2-(Difluoromethyl)-4-methylpyridine-5-sulfonyl chloride is characterized by its fluorine-containing substituents, which significantly influence its chemical reactivity and biological activity. The 2-(difluoromethyl) group introduces electron-withdrawing effects, modulating the compound's interactions with biological targets. This structural feature is particularly relevant in the context of drug discovery, where subtle changes in molecular architecture can lead to improved pharmacokinetic profiles and enhanced therapeutic efficacy. Studies published in 2023 in the Journal of Medicinal Chemistry have demonstrated the utility of similar fluorinated pyridine derivatives in the design of kinase inhibitors and ion channel modulators, underscoring the importance of this compound in modern medicinal chemistry.

Recent research has focused on the synthetic routes and functionalization strategies for 2-(Difluoromethyl)-4-methylpyridine-5-sulfonyl chloride. One notable advancement involves the use of electrophilic substitution reactions to introduce additional functional groups, such as hydroxyl or amino moieties, which can be tailored for specific therapeutic applications. A 2023 study in the Organic & Biomolecular Chemistry journal reported the successful synthesis of 5-sulfonyl derivatives with enhanced solubility and stability, addressing common challenges in the development of pyridine-based drugs. These findings highlight the compound's adaptability to diverse chemical environments, making it a valuable tool for researchers exploring targeted drug delivery systems.

The 5-sulfonyl chloride functionality of 2-(Difluoromethyl)-4-methylpyridine-5-sulfonyl chloride is particularly significant in the context of peptide chemistry and protein engineering. This group can act as a cross-linker or conjugation site for attaching biomolecules such as antibodies, peptides, or carbohydrates. A 2023 review in Advanced Drug Delivery Reviews emphasized the role of sulfonyl chloride derivatives in the development of targeted therapies, where they enable the precise modification of drug molecules to improve their interaction with specific cellular receptors. This application is particularly relevant in the field of oncology, where site-specific conjugation can enhance the efficacy of therapeutic agents.

From a mechanistic perspective, 2-(Difluoromethyl)-4-methylpyridine-5-sulfonyl chloride is often employed as a precursor in the synthesis of heterocyclic compounds with potential pharmaceutical applications. The pyridine ring structure, combined with the sulfonyl chloride functionality, allows for the creation of complex molecules with diverse biological activities. For instance, recent studies have explored its use in the development of anti-inflammatory agents and antimicrobial compounds, leveraging the electron-deficient nature of the 5-sulfonyl group to modulate interactions with biological targets. These efforts reflect the growing importance of structure-based drug design in modern pharmaceutical research.

Moreover, the fluorinated substituents in 2-(Difluoromethyl)-4-methylpyridine-5-sulfonyl chloride contribute to its metabolic stability and bioavailability. Fluorine atoms are known to enhance the hydrophobicity of molecules, which can prolong their residence time in biological systems. This property is particularly advantageous for drugs targeting intracellular pathways, where prolonged exposure to the target site can improve therapeutic outcomes. A 2023 study in Bioorganic & Medicinal Chemistry demonstrated that fluorinated pyridine derivatives exhibit improved cellular uptake and targeting efficiency compared to their non-fluorinated counterparts, further validating the utility of this compound in drug development.

The synthetic versatility of 2-(Difluoromethyl)-4-methylpyridine-5-sulfonyl chloride also extends to its potential applications in material science and nanotechnology. Researchers have explored its use in the fabrication of drug-loaded nanoparticles and smart polymers, where its chemical reactivity allows for the controlled release of therapeutic agents. A 2023 publication in ACS Nano highlighted the development of fluorinated pyridine-based nanocarriers capable of delivering targeted therapies with high precision. These innovations underscore the interdisciplinary relevance of this compound beyond traditional pharmaceutical applications.

In conclusion, 2-(Difluoromethyl)-4-methylpyridine-5-sulfonyl chloride represents a pivotal compound in the field of synthetic chemistry and pharmaceutical research. Its unique structural features, including the fluorinated substituents and 5-sulfonyl chloride functionality, enable its application in the development of a wide range of therapeutic agents. Ongoing research continues to uncover new functionalization strategies and mechanistic insights, further solidifying its role as a key player in the advancement of modern medicine.

For further information on the synthesis, applications, and biological activity of 2-(Difluoromethyl)-4-methylpyridine-5-sulfonyl chloride, researchers are encouraged to consult recent publications in leading pharmaceutical journals and organic chemistry databases. These resources provide detailed insights into the chemical properties and potential therapeutic applications of this compound, supporting its continued exploration in both academic and industrial settings.

As the field of drug discovery continues to evolve, compounds like 2-(Difluoromethyl)-4-methylpyridine-5-sulfonyl chloride will remain at the forefront of innovation, offering new opportunities to address complex medical challenges. Their adaptability, combined with the growing sophistication of synthetic methods, ensures that they will play an increasingly important role in the development of next-generation therapeutic agents.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)